NCT02557139View on ClinicalTrials.gov

Bioavailability of Belumosudil (KD025) in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 12, 2015

Study Completion Date

October 12, 2015

Conditions

Bioavailability

Interventions

DRUG

Belumosudil Tablet

DRUG

Belumosudil Capsule

Trial Locations (1)

NG116JS

Quotient Clinical Limited, Ruddington Nottingham

Sponsors

Collaborators (1)

Quotient Clinical

All Listed Sponsors

collaborator

Quotient Clinical

OTHER

lead

Kadmon Corporation, LLC

INDUSTRY

NCT02557139 - Bioavailability of Belumosudil (KD025) in Healthy Male Subjects | Biotech Hunter | Biotech Hunter